Daphnee Moise-Johnson, MD
General Practice · Sarasota, FLNPI 1871546788
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Merz North America, Inc. at 56.4% of the total. That places this record below the midpoint for general practice clinicians in FL, where the typical reported total is $253.
Across 7 payments — averaging $41.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$164
- Revance Therapeutics, Inc.$47
- Dexcom, Inc.$24
- Novartis$20
- AstraZeneca$19
- CSL Behring$17
Across 1,048 payments — averaging $1602.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$862K
- Seqirus USA Inc$795K
- Pfizer$22K
What the payments were for
- Food & beverage$291100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 2 | $164 |
| Revance Therapeutics, Inc. | 1 | $47 |
| Dexcom, Inc. | 1 | $24 |
| Novartis | 1 | $20 |
| AstraZeneca | 1 | $19 |
| CSL Behring | 1 | $17 |
How this compares
$291 in reported general payments places this provider in the 50th percentile of 6,901 general practice providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other general practice in Sarasota
- Mario RomeroSarasota$275K
- Robert VogelPalm Beach Gardens$1M
- Bruce OuelletteWest Palm Beach$724K
- Caley CasteleinMiami Beach$586K
- Sarah JockinTampa$308K
- Robert RitterJupiter$233K
- Robert AltharPensacola$231K
- Florencia ZiemkeWest Palm Beach$208K
- Ausberto HidalgoPembroke Pines$171K
- Rickie FergusonPembroke Pines$170K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.